The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis
Open accessAbstract
BACKGROUND AND AIMS Cholangiocarcinoma (CCA) carries a poor prognosis, is increasing in incidence and its causes are poorly understood. Although some risk factors are known, they vary globally and collectively account for a minority of cases. This study aimed to perform a comprehensive meta-analysis of risk factors for intrahepatic (iCCA) and extrahepatic cholangiocarcinoma (eCCA), from Eastern and Western world studies. METHODS A literature search of case-control studies was performed to identify potential risk factors for iCCA and eCCA. Pooled odds ratios (OR) with 95% confidence intervals and heterogeneity were calculated. Funnel plots were used to assess for publication bias, and meta-regression for select risk factors to compare East versus West studies. RESULTS 13 risk factors were selected from 25 case-control studies in seven geographically diverse countries. The strongest risk factors for both iCCA and eCCA were biliary cysts and stones, cirrhosis, hepatitis B and hepatitis C. Choledochal cysts inferred the greatest risk of both iCCA and eCCA with pooled OR of 26.71 (95% CI, 15.80-45.16) and 34.94 (24.36-50.12), respectively. No significant associations were found between hypertension and obesity for either iCCA or eCCA. Comparing Eastern and Western populations, there was a difference for the association of hepatitis B with iCCA (coefficient= -0.15195; 95% CI, -0.278 to -0.025; p= 0.022). CONCLUSION This is the most comprehensive meta-analysis of CCA risk factors to date. Some risk factors, such as diabetes, although less strong, are increasing globally and may be contributing to rising rates of this cancer. LAY SUMMARY Cholangiocarcinoma (CCA) is a cancer arising in the bile ducts inside (intrahepatic CCA, iCCA) and connected to the liver (extrahepatic, eCCA). It is a very aggressive cancer: 95% of patients die within five years. CCA rates are increasing globally, but the causes of CCA are poorly understood. Those few risk factors that are known account for only a minority of cases. This study aimed to combine and analyse data from previous studies to clarify and quantify the risk factors for CCA and compare them in Eastern and Western countries. The strongest risk factors for both iCCA and eCCA are cysts and stones in the bile ducts, cirrhosis and viruses hepatitis B and C. Some risk factors for CCA, such as diabetes, although relatively less strong, are increasing globally and may be contributing to rising rates of this cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Cholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Self-citationEpidemiology of Gallbladder Disease: Cholelithiasis and Cancer
Stinton, L. M., & Shaffer, E. A. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.2.172 · Cited by 1,381
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Ilyas, S. I., & Gores, G. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.013 · Cited by 1,307
Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution
DeOliveira, M. L., Cunningham, S. C., Cameron, J. L., Kamangar, F., Winter, J. M., Lillemoe, K. D., Choti, M. A., Yeo, C. J., & Schulick, R. D. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251366.62632.d3 · Cited by 1,300
Cholangiocarcinoma: A Spectrum of Intrahepatic, Perihilar, and Distal Tumors
Nakeeb, A., Pitt, H. A., Sohn, T. A., Coleman, J., Abrams, R. A., Piantadosi, S., Hruban, R. H., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00005 · Cited by 1,187
Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., & Srishord, M. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,073
Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.25087 · Cited by 1,010
Risk factors for cholangiocarcinoma
Tyson, G. L., & El-Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24351 · Cited by 956
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 860
Ottawa Hospital Research Institute
(2015) · The SAGE Encyclopedia of Stem Cell Research · doi:10.4135/9781483347660.n335 · Cited by 855
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
Saha, S. K., Zhu, A. X., Fuchs, C. S., & Brooks, G. A. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0446 · Cited by 786
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
Khan, S. A., Taylor-Robinson, S. D., Toledano, M. B., Beck, A., Elliott, P., & Thomas, H. C. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00297-0 · Cited by 570
Self-citationRisk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
Shaib, Y. H., El-Serag, H. B., Davila, J. A., Morgan, R., & McGlynn, K. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.048 · Cited by 546
Welzel, T. M., Graubard, B. I., Zeuzem, S., El-Serag, H. B., Davila, J. A., & McGlynn, K. A. (2011) · Hepatology · doi:10.1002/hep.24397 · Cited by 543
Palmer, W. C., & Patel, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.022 · Cited by 517
Welzel, T. M., Graubard, B. I., El–Serag, H. B., Shaib, Y. H., Hsing, A. W., Davila, J. A., & McGlynn, K. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.020 · Cited by 514
Burke, E. C., Jarnagin, W. R., Hochwald, S. N., Pisters, P. W. T., Fong, Y., & Blumgart, L. H. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00011 · Cited by 468
Epidemiology of cholangiocarcinoma: An update focusing on risk factors
Shin, H., Oh, J., Masuyer, E., Curado, M., Bouvard, V., Fang, Y., Wiangnon, S., Sripa, B., & Hong, S. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01458.x · Cited by 454
Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data
Leon, D. A., & McCambridge, J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67924-5 · Cited by 445
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998
Taylor-Robinson, S. D., Toledano, M. B., Arora, S., Keegan, T. J., Hargreaves, S., Beck, A., Khan, S. A., Elliott, P., & Thomas, H. C. (2001) · Gut · doi:10.1136/gut.48.6.816 · Cited by 381
Self-citationDiagnosis and Treatment of Cholangiocarcinoma
Anderson, C. D., Wright Pinson, C., Berlin, J., & Chari, R. S. (2004) · The Oncologist · doi:10.1634/theoncologist.9-1-43 · Cited by 332
Opisthorchiasis control in Thailand
Jongsuksuntigul, P., & Imsomboon, T. (2003) · Acta Tropica · doi:10.1016/j.actatropica.2003.01.002 · Cited by 265
Shaib, Y. H., El-Serag, H. B., Nooka, A. K., Thomas, M., Brown, T. D., Patt, Y. Z., & Hassan, M. M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01104.x · Cited by 258
Donato, F., Gelatti, U., Tagger, A., Favret, M., Ribero, M. L., Callea, F., Martelli, C., Savio, A., Trevisi, P., & Nardi, G. (2001) · Cancer Causes & Control · doi:10.1023/a:1013747228572 · Cited by 247
Dasgupta, P., Henshaw, C., Youlden, D. R., Clark, P. J., Aitken, J. F., & Baade, P. D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00171 · Cited by 238
Roles of liver fluke infection as risk factor for cholangiocarcinoma
Sithithaworn, P., Yongvanit, P., Duenngai, K., Kiatsopit, N., & Pairojkul, C. (2014) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.62 · Cited by 231
Changes in incidence of diabetes in U.S. adults, 1997–2003
Geiss, L. S., Pan, L., Cadwell, B., Gregg, E. W., Benjamin, S. M., & Engelgau, M. M. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.12.009 · Cited by 229
Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study
Lee, T. Y., Lee, S. S., Jung, S. W., Jeon, S. H., Yun, S.-C., Oh, H.-C., Kwon, S., Lee, S. K., Seo, D. W., Kim, M.-H., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01796.x · Cited by 217
Petrick, J. L., Yang, B., Altekruse, S. F., Van Dyke, A. L., Koshiol, J., Graubard, B. I., & McGlynn, K. A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186643 · Cited by 210
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors
Cardinale, V. (2010) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v2.i11.407 · Cited by 197
Welzel, T. M., Mellemkjaer, L., Gloria, G., Sakoda, L. C., Hsing, A. W., Ghormli, L. E., Olsen, J. H., & McGlynn, K. A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22283 · Cited by 195
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
Yamamoto, S., Kubo, S., Hai, S., Uenishi, T., Yamamoto, T., Shuto, T., Takemura, S., Tanaka, H., Yamazaki, O., Hirohashi, K., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02492.x · Cited by 187
Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China
Zhou, Y.-M., Yin, Z.-F., Yang, J.-M., Li, B., Shao, W.-Y., Xu, F., Wang, Y.-L., & Li, D.-Q. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.632 · Cited by 171
Mosconi, S., Beretta, G. D., Labianca, R., Zampino, M. G., Gatta, G., & Heinemann, V. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.09.008 · Cited by 163
Inflammatory bowel disease incidence: up, down or unchanged?
Logan, R. F. (1998) · Gut · doi:10.1136/gut.42.3.309 · Cited by 154
Chaiteerakij, R., Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Mettler, T. A., Fredericksen, Z. S., Kim, W. R., Gores, G. J., Roberts, R. O., Olson, J. E., et al. (2012) · Hepatology · doi:10.1002/hep.26092 · Cited by 153
Bertuccio, P., Bosetti, C., Levi, F., Decarli, A., Negri, E., & Vecchia, C. L. (2013) · Annals of Oncology · doi:10.1093/annonc/mds652 · Cited by 135
Lee, C. H., Chang, C. J., Lin, Y.-H., Yeh, C.-N., Chen, M. F., & Hsieh, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605063 · Cited by 131
Diabetes mellitus and increased risk of cholangiocarcinoma
Jing, W., Jin, G., Zhou, X., Zhou, Y., Zhang, Y., Shao, C., Liu, R., & Hu, X. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3283481d89 · Cited by 121
Aspirin use and the risk of cholangiocarcinoma‡
Choi, J., Ghoz, H. M., Peeraphatdit, T. B., Baichoo, E., Addissie, B. D., Harmsen, W. S., Therneau, T. M., Olson, J. E., Chaiteerakij, R., & Roberts, L. R. (2016) · Hepatology · doi:10.1002/hep.28529 · Cited by 120
Li, Y., Yang, H., & Cao, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018776 · Cited by 119
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells
Simone, V. D., Ciavarella, S., Brunetti, O., Savonarola, A., Cives, M., Tucci, M., Opinto, G., Maiorano, E., & Silvestris, F. (2015) · BMC Cancer · doi:10.1186/s12885-015-1717-8 · Cited by 113
Zhou, Y., Zhao, Y., Li, B., Huang, J., Wu, L., Xu, D., Yang, J., & He, J. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-289 · Cited by 107
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case–control study in China
Tao, L., He, X., Qu, Q., Cai, L., Liu, W., Zhou, L., & Zhang, S.-M. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02149.x · Cited by 100
Petrick, J. L., Sahasrabuddhe, V. V., Chan, A. T., Alavanja, M. C. R., Freeman, L. E. B., Buring, J. E., Chen, J., Chong, D. Q., Freedman, N. D., Fuchs, C. S., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0126 · Cited by 95
Li, M., Li, J., Li, P., Li, H., Su, T., Zhu, R., & Gong, J. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07207.x · Cited by 88
Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis
Ren, H., Yu, T., Liu, C., & Li, Y. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9754-3 · Cited by 88
Hsing, A. W., Zhang, M.-D., Rashid, A., McGlynn, K. A., Wang, B., Niwa, S., Ortiz‐Conde, B. A., Goedert, J. J., Fraumeni, J. F., OʼBrien, T. R., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23251 · Cited by 86
Risk Factors for Cholangiocarcinoma in Thailand: A Systematic Review and Meta-Analysis
Kamsa‐ard, S., Kamsa‐ard, S., Luvira, V., Suwanrungruang, K., Vatanasapt, P., & Wiangnon, S. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.3.605 · Cited by 86
Chang, J. S.-M., Tsai, C., & Chen, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069981 · Cited by 83
Xia, J., Jiang, S., & Peng, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132673 · Cited by 73
Thomson, S. J., Westlake, S. K., Rahman, T. M., Cowan, M., Majeed, A., Maxwell, J. D., & Kang, J. Y. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn020 · Cited by 73
Li, H., Hu, B., Zhou, Z., Guan, J., Zhang, Z., & Zhou, G.-W. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0583-9 · Cited by 71
Godos, J., Micek, A., Marranzano, M., Salomone, F., Rio, D. D., & Ray, S. (2017) · Nutrients · doi:10.3390/nu9090950 · Cited by 69
Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA)
Chow, W.-H., McLaughlin, J. K., Menck, H. R., & Mack, T. M. (1994) · Cancer Causes & Control · doi:10.1007/bf01830247 · Cited by 66
Li, L., Gan, Y., Li, W., Wu, C., & Lu, Z. (2016) · Obesity · doi:10.1002/oby.21505 · Cited by 61
Huai, J., Ding, J. W., Ye, X., & Chen, Y. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.8.3477 · Cited by 58
Park, M., Song, D. Y., Je, Y., & Lee, J. E. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.03.027 · Cited by 53
Lee, B. S., Park, E.-C., Park, S. W., Nam, C. M., & Roh, J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i2.502 · Cited by 51
Obesity and the risk of cholangiocarcinoma: a meta-analysis
Li, J.-S., Han, T., Jing, N., Li, L., Zhang, X., Ma, F.-Z., & Liu, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-1939-4 · Cited by 50
Aspirin Use and Risk of Biliary Tract Cancer: A Population-Based Study in Shanghai, China
Liu, E., Sakoda, L. C., Gao, Y.-T., Rashid, A., Shen, M.-C., Wang, B.-S., Deng, J., Han, T., Zhang, B., Fraumeni, J. F., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0032 · Cited by 48
Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
Pant, K., Richard, S., Peixoto, E., & Gradilone, S. A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00113 · Cited by 47
The Metabolic Syndrome and Risk Factors for Biliary Tract Cancer: A Case-control Study in China
Wu, Q., He, X., Yu, L., Liu, W., & Tao, L. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.5.1963 · Cited by 44
Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: A meta-analysis
Ye, X. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i46.8780 · Cited by 43
Zhou, Y., Zhou, Q., Lin, Q., Chen, R., Gong, Y., Liu, Y., Yu, M., Zeng, B., Li, K., Chen, R., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28196 · Cited by 40
Yang, H., He, F., Wang, T., Liu, Y., Shen, Y., Gong, J., Dai, W., Zhou, J., Gu, J., Tu, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117946 · Cited by 33
Pastore, M., Lori, G., Gentilini, A., Taddei, M. L., Maira, G. D., Campani, C., Recalcati, S., Invernizzi, P., Marra, F., & Raggi, C. (2020) · Cells · doi:10.3390/cells9030596 · Cited by 28
Perdikis, D., Volhard, J., Müller, V., Kaulard, K., Brick, T. R., Wallraven, C., & Lindenberger, U. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181225 · Cited by 26
Aspirin May Prevent Cholangiocarcinoma: A Case–Control Study from the United Kingdom
Burr, N. E., Talboys, R., Savva, S., Clark, A., Phillips, M. G., Metcalfe, M. S., Dennison, A. R., Robinson, R., Lewis, M. P., Rhodes, M. A., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3056-z · Cited by 25
Seventy Years of Gastroenterology (1943–2013)
Goyal, R. K. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.020 · Cited by 13
Xiao, W., Zhou, Y., Yu, P., Yang, A., Zheng, S., Tang, H., & Xie, X. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.01.97 · Cited by 7
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationKelley, R. K., Ueno, M., Yoo, C., Finn, R. S., Furuse, J., Ren, Z., Yau, T., Klümpen, H.-J., Chan, S. L., Ozaka, M., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00727-4 · Cited by 1,169
Self-citationValle, J. W., Kelley, R. K., Nervi, B., Oh, D.-Y., & Zhu, A. X. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00153-7 · Cited by 1,043
Brindley, P. J., Bachini, M., Ilyas, S. I., Khan, S. A., Loukas, A., Sirica, A. E., Teh, B. T., Wongkham, S., & Gores, G. J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00300-2 · Cited by 841
Self-citationBiliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Vogel, A., Bridgewater, J., Edeline, J., Kelley, R. K., Klümpen, H. J., Malka, D., Primrose, J. N., Rimassa, L., Stenzinger, A., Valle, J. W., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2022.10.506 · Cited by 718
Metadata
- Authors
- Clements, O., Eliahoo, J., Kim, J. U., Taylor-Robinson, S. D., & Khan, S. A.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 72
- Issue
- 1
- Pages
- 95-103
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2973596517
- Cited by
- 550
- References
- 72
- FWCI
- 12.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.